Time filter

Source Type

Oh D.-R.,Jeonnam Institute of Natural Resources Research JINR | Oh D.-R.,Chonnam National University | Kim Y.,Jeonnam Institute of Natural Resources Research JINR | Choi E.-J.,Jeonnam Institute of Natural Resources Research JINR | And 6 more authors.
Evidence-based Complementary and Alternative Medicine | Year: 2016

Background. The objective of the present study was to perform a bioguided fractionation of unripe Rubus coreanus Miquel (uRC) and evaluate the lipid accumulation system involvement in its antiobesity activity as well as study the uRC mechanism of action. Results. After the fractionation, the BuOH fraction of uRC (uRCB) was the most active fraction, suppressing the differentiation of 3T3-L1 adipocytes in a dose-dependent manner. Moreover, after an oral administration for 8 weeks in HFD-induced obese mice, uRCB (10 and 50 mg/kg/day) produced a significant decrease in body weight, food efficiency ratio, adipose tissue weight and LDL-cholesterol, serum glucose, TC, and TG levels. Similarly, uRCB significantly suppressed the elevated mRNA levels of PPARγ in the adipose tissue in vivo. Next, we investigated the antiobesity effects of ellagic acid, erycibelline, 5-hydroxy-2-pyridinemethanol, m-hydroxyphenylglycine, and 4-hydroxycoumarin isolated from uRCB. Without affecting cell viability, five bioactive compounds decreased the lipid accumulation in the 3T3-L1 cells and the mRNA expression levels of key adipogenic genes such as PPARγ, C/EBPα, SREBP-1c, ACC, and FAS. Conclusion. These results suggest that uRC and its five bioactive compounds may be a useful therapeutic agent for body weight control by downregulating adipogenesis and lipogenesis. © 2016 Dool-Ri Oh et al.

Jung M.-A.,Jeonnam Institute of Natural Resources Research JINR | Lee S.Y.,Jeonnam Institute of Natural Resources Research JINR | Han S.H.,Jeonnam Institute of Natural Resources Research JINR | Hong J.,Jeonnam Institute of Natural Resources Research JINR | And 4 more authors.
Animal Cells and Systems | Year: 2015

Hypercholesterolemia is one of the well-established risk factors for cardiovascular mortality and morbidity in coronary heart disease. The present study was designed to investigate the effects of different types of extracts (aqueous, 20%-, and 80% ethanol) of Nelumbo nucifera leaf (NL) and Curcuma Longa L. (CL) on hypercholesterolemia in in vitro and in vivo models. Our results in in vitro experiments showed that treatment with various extracts of both NL and CL dose-dependently inhibited lipid accumulation and total cholesterol content. The 20% ethanol extract of NL (NL20E) and the aqueous extract of CL (CLW) showed the highest activity. The in vivo experimental group was fed a high cholesterol diet (HCD) with oral administration of NL20E, CLW, or a mixture of NL20E with CLW (NC; mixed equal ratio) for 8 weeks. The oral administration of NL20E, CLW, and NC (100 or 300 mg/kg/day) resulted in the suppression of the levels of serum total cholesterol (TC), low-density lipoprotein (LDL)-cholesterol, liver lipid level, glutamic oxaloacetic transaminase (GOT), glutamic pyruvic transaminase (GPT), atherogenic index (AI), cardiac risk factor (CRF), cholesteryl ester transfer protein (CETP), HMG-CoA reductase, and thiobarbituric acid-reactive substances (TBARS). Similarly, the NL20E, CLW, and NC extracts elevated high-density lipoprotein (HDL) cholesterol levels and lecithin cholesterol acyltransferase (LCAT) activity. Furthermore, NC showed a remarkable hypocholesterolemic effect by decreasing the levels of hepatic TC, AI, LDL cholesterol, HMG-CoA reductase, and CRE and by increasing the levels of HDL cholesterol. Thus, the results of this study indicate that the NC has combined hypocholesterolemic effects that block lipid accumulation, thus preventing hypercholesterolemia. © 2015, © 2015 Korean Society for Integrative Biology.

Discover hidden collaborations